Recall Register

Food, drugs, devices › Ortho-Clinical Diagnostics

Device recall: VITROS CRP Slides: 1) VITROS¿ Chemistry Products CRP Slides (250 slides per sales unit), Catalog # 1926740 and 2) , VITR

FDA enforcement event 75692 · Class III · initiated 26 Oct 2016 · status Terminated · terminated 22 Jun 2018

DeviceVoluntary: Firm initiated1 product recordRochester, NY

Ortho-Clinical Diagnostics (Rochester, NY) initiated this device recall on 26 Oct 2016; FDA lists 1 product record under event 75692, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 5% of the 1,232 device enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 22 Jun 2018. Initiation: voluntary: firm initiated. Ortho-Clinical Diagnostics has 105 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Ortho-Clinical Diagnostics, Rochester, NY.

Reason for recall

"CRP samples diluted using VITROS Chemistry Products Specialty Diluent, VITROS Chemistry Products FS Diluent Pack 3, or a sample with a low concentration of CRP had positively biased results if the endogenous level of CRP in the diluent is not subtracted from the final result. The IFUs do not provide specific instructions for how to account for endogenous CRP in the diluent when calculating the…"

Distribution

"Worldwide Distribution - USA (nationwide) Distribution including Puerto Rico, and to the countries of : Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, India, Japan, Mexico, Republic of…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0864-2017VITROS CRP Slides: 1) VITROS¿ Chemistry Products CRP Slides (250 slides per sales unit), Catalog # 1926740 and 2) , VITROS¿ Chemistry Products CRP Slides (90 slides per sales unit), Catalog # 1926740124,063 unitsClass IIITerminated28 Dec 2016

Context

5%of 2016 device events are Class III1,232 events that year
1product record in this eventfirm median: 1
105events on this register for the firm

Other enforcement events for Ortho-Clinical Diagnostics

InitiatedProduct (first record)TypeClassRecords
27 Feb 2024VITROS Performance Verifier IDeviceClass II2
5 Jun 2023VITROS Immunodiagnostic Products Troponin I ES Reagent PackDeviceClass II2
8 May 2023VITROS Chemistry Products Calibrator Kit 20-in vitro diagnostic use only. VITROS Chemistry Products Calibrator Kit 20- UDeviceClass II1
20 Jul 2020VITROS XT3400 Chemistry System, Product code 6844458DeviceClass II2
17 Jul 2020VITROS Anti-SARS-CoV-2 Total Reagent, COV2TOT, VITROS CoV2T. Catalog number 6199922, UDI 10758750033386 - Product Usage:DeviceClass II2
13 Jul 2020VITROS Chemistry Products TBIL Slides- 5 PACK/300 SLDS In vitro Diagnostic quantitatively measure total bilirubin (TBIL)DeviceClass II3
20 May 2020VITROS 3600 Immunodiagnostic System Software Versions 3.3.3 and below Product Code: 6802783, Unique Identifier: 10758750DeviceClass II5
11 May 2020VITROS Chemistry Product AMYL Slides Reagent, AMYLASE/5 PACK/300 SLDS, Product Code 1202670, UDI # 10758750008513 - ProdDeviceClass II4
1 Apr 2020VITROS Chemistry Products CKMB Slides, Creatine Kinase MB, Product Code 805 8232-300 slides, UDI Number 10758750004294 -DeviceClass II2
10 Mar 2020VITROS Immunodiagnostic Products TT4 Reagent Pack, Product Code 8744468DeviceClass III1

All 105 events for Ortho-Clinical Diagnostics

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "CRP samples diluted using VITROS Chemistry Products Specialty Diluent, VITROS Chemistry Products FS Diluent Pack 3, or a sample with a low concentration of CRP had positively biased results if the endogenous level of CRP in the diluent is not subtracted from the final result. The IFUs do not provide specific instructions for how to account for endogenous CRP in the diluent when calculating the…"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - USA (nationwide) Distribution including Puerto Rico, and to the countries of : Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, India, Japan, Mexico, Republic of…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 22 Jun 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.